Roivant Sciences (ROIV) shares outstanding
Roivant Sciences (ROIV) had 693.86M diluted shares on average in fiscal 2026 (the year ended March 31, 2026). That is 4.3% lower than the 725.40M of fiscal 2025. Figures as of 18 Nov 2026, 10:48 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- Shares outstanding, fiscal 2026
- 693.86M
- Change on fiscal 2025
- −4.3%
- Highest on record
- 831.05Mfiscal 2024
- Lowest on record
- 669.75Mfiscal 2022
- Fiscal years on record
- 52022–2026
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.
Roivant Sciences shares outstanding, in more detail
The market data feed counts 724.56M shares outstanding today.
Across the 5 fiscal years on record (2022–2026), the highest was 831.05M in fiscal 2024 and the lowest 669.75M in fiscal 2022.
Shares outstanding by fiscal year
Roivant Sciences shares outstanding, year by year
| Fiscal year | Shares outstanding | Change | Year ended |
|---|---|---|---|
| 2026 | 693.86M | 4.3% down | |
| 2025 | 725.40M | 12.7% down | |
| 2024 | 831.05M | 16.6% up | |
| 2023 | 712.79M | 6.4% up | |
| 2022 | 669.75M | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.
How to read it
A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.
Shares outstanding at health care companies of similar size
| Company | Shares outstanding | Fiscal year |
|---|---|---|
| Labcorp Holdings LH | 83.80M | 2025 |
| DexCom DXCM | 405.50M | 2025 |
| Koninklijke Philips PHG | 962.50M | 2025 |
| Roivant Sciences ROIV | 693.86M | 2026 |
| West Pharmaceutical Services WST | 72.70M | 2025 |
| Quest Diagnostics DGX | 113.00M | 2025 |
The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.
Roivant Sciences, figure by figure
- Roivant Sciences market cap
- Roivant Sciences revenue
- Roivant Sciences earnings
- Roivant Sciences earnings per share (EPS)
- Roivant Sciences P/E ratio
- Roivant Sciences P/S ratio
- Roivant Sciences P/B ratio
- Roivant Sciences free cash flow
- Roivant Sciences operating margin
- Roivant Sciences dividend
- Roivant Sciences total debt
- Roivant Sciences cash on hand
- Roivant Sciences total assets
- Roivant Sciences return on equity (ROE)
- Roivant Sciences return on invested capital (ROIC)
Roivant Sciences (ROIV) overview: price, valuation and scorecardAll health care companies by market value
Roivant Sciences shares outstanding: questions and answers
How many shares does Roivant Sciences have?
Roivant Sciences (ROIV) had 693.86M diluted shares on average in fiscal 2026 (the year ended March 31, 2026). That is 4.3% lower than the 725.40M of fiscal 2025. The market data feed counts 724.56M shares outstanding today.
What are the highest and lowest diluted share count figures on record for Roivant Sciences?
Across the 5 fiscal years on record (2022–2026), the highest was 831.05M in fiscal 2024 and the lowest 669.75M in fiscal 2022.
How is Roivant Sciences's diluted share count calculated?
The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Roivant Sciences it is on record here for 5 fiscal years, 2022 to 2026.
Fiscal years are named for the calendar year they end in.
Learn: shares outstanding
All stocks guides →- What market capitalization is, and what it is not
Market capitalization is the share price multiplied by the number of shares outstanding: 1 billion shares at $50 is a $50 billion company. It measures the size the stock market puts on a company's equity today. It is not a sale price, it ignores debt and cash, and index providers often count only the freely traded part, the float.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
Cite this page
Funkfolio, “Roivant Sciences (ROIV) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/ROIV/shares-outstanding
Underlying data: the company's filings with the SEC and Yahoo Finance.